AbobutulinumtoxinA

· Galderma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AbobutulinumtoxinA, covering 2020-03-18 to 2020-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Subject Satisfaction With AbobutulinumtoxinA Treatment [Phase 4]